Hannah S Coalson Selected Research

Electron Transport Complex I (NADH-CoQ Reductase)

1/2022

Alterations in sphingolipid composition and mitochondrial bioenergetics represent synergistic therapeutic vulnerabilities linked to multidrug resistance in leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hannah S Coalson Research Topics

Disease

3	Neoplasms (Cancer) 10/2023 - 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Leukemia 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021

Drug/Important Bio-Agent (IBA)

2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2021
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 10/2023
1	ProteomeIBA 10/2023
1	Phosphotransferases (Kinase)IBA 01/2022
1	SphingolipidsIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2022
1	Adenylate KinaseIBA 01/2022
1	CalciumIBA 01/2022
1	P(1),P(5)- di(adenosine- 5'- )pentaphosphateIBA 01/2022

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022